Noninvasive Hemoglobin Monitoring by Spectrophotometry (SpHb) in Blunt Abdominal Trauma Patients for Conservative Management

Ain Shams University1 site in 1 country30 target enrollmentNovember 22, 2021

ConditionsIntensive Care Unit

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Intensive Care Unit
Sponsor: Ain Shams University
Enrollment: 30
Locations: 1
Primary Endpoint: accuracy of hemoglobin measured by the noninvasive device.
Last Updated: 3 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

We aimed to study the efficacy of Noninvasive Hemoglobin Monitoring by Spectrophotometry in monitoring hemoglobin level in trauma patients for conservative management.

Registry

clinicaltrials.gov

Start Date

November 22, 2021

End Date

August 22, 2022

Last Updated

3 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

Ain Shams University

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•American Society of Anesthesiologists (ASA) physical status I to III, of either sex, 18 -80 years of age, non-sedated non-intubated patients who will be admitted to Ain Shams university hospital - surgical intensive care unit, after blunt abdominal trauma planned for conservation.

Exclusion Criteria

•Patients with fever, hypothermia, history of a neurological, psychiatric, dementia or, who are taking psychotropic drugs Patients with unstable hemodynamic status, and unconscious patients.

Outcomes

Primary Outcomes

accuracy of hemoglobin measured by the noninvasive device.

Time Frame: 3 months

accuracy of hemoglobin measured by the noninvasive hemoglobin test device (Radical-7®; Masimo Corp., Irvine, CA) in comparison with standard CBC that is assayed on Coulter LH 750 Cell Counter (Beckman Coulter Corporation, Florida, USA), using reagents supplied by the company in patients suffering frm blunt abdominal trauma aditted to ICU for observation.